Monday, May 20, 2002

ASCO 2002 Drs Metz and Hahn
James Metz, MD, OncoLink Editor-in-Chief, and Stephen Hahn, MD, Associate Professor of Radiation Oncology at the Unversity of Pennsylvania

A Phase II Trial Of Pemetrexed In Malignant Pleural Mesothelioma (MPM) Patients: Clinical Outcome, Role Of Vitamin Station, Respiratory Symptoms Upplemenand Lung Function Cisplatin And Etoposide Plus Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy (TRT) Followed By Three Cycles Of Irinotecan And Cisplatin For The Treatment Of Limited-Stage Small-Cell Lung Cancer (SCLC); Updated Results: JCOG 9903-DI Initial Results Of Preoperative Gemcitabine (GEM)-Based Chemoradiation For Resectable Pancreatic Adenocarcinoma Phase II Study Of STI571 (GleevecTM) For Patients With Small Cell Lung Cancer Phase III single-blinded study of premexetred + cisplatin vs. cisplatin alone in chemonaive patients with malignant pleural mesothelioma PSA Testing Interval Reduction In Screening Intervals: Data From The Prostate, Lung, Colorectal And Ovarian Cancer (PLCO) Screening Trial Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) Responding to the IOM?s Challenge to Improve Palliative Care: Nurse/Physician Collaborative Care Model Risk-reducing salpingo-oopherectomy in women with BRCA1 and BRCA2 mutations Single-Agent (SA) Versus Combination Chemotherapy (CC) In Advanced Non-Small Cell Lung Cancer (NSCLC): A CALGB Randomized Trial Of Efficacy, Quality Of Life (QoL), And Cost-Effectiveness STI-571 (Gleevac/Glivec, imatinib) versus interferon (IFN) + cytarabine as initial therapy for patients with CML: results of a randomized study SWOG 0004 - Pilot Study Of Tirapazamine (TPZ) Plus Cisplatin/Etoposide (PE) And Concurrent Thoracic Radiotherapy (RT) In Limited Small Cell Lung Cancer (LSCLC)


Click on any of these terms for more related articles


Resources for Vegetarian Cooking
by OncoLink Editorial Team
February 25, 2013